Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0009 |